NEU 3.50% $14.05 neuren pharmaceuticals limited

New CEO at Pfizer has a totally different perspective on things...

  1. 597 Posts.
    New CEO at Pfizer has a totally different perspective on things from the previous one. Apparently he is not so keen on NEU or its science type.

    Watch out below. Even NEU know its no good. Its why they have gone in for cancer surreptitiously.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.